Department of Physiology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China.
Department of Physiology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People's Republic of China; Hebei Technology Innovation Center of TCM Combined Hydrogen Medicine, Shijiazhuang, Hebei, People's Republic of China.
J Ethnopharmacol. 2023 Oct 28;315:116677. doi: 10.1016/j.jep.2023.116677. Epub 2023 Jun 1.
Chronic intermittent hypoxia (CIH) is the primary pathophysiological process of obstructive sleep apnea (OSA) and is closely linked to neurocognitive dysfunction. Tanshinone IIA (Tan IIA) is extracted from Salvia miltiorrhiza Bunge and used in Traditional Chinese Medicine (TCM) to improve cognitive impairment. Studies have shown that Tan IIA has anti-inflammatory, anti-oxidant, and anti-apoptotic properties and provides protection in intermittent hypoxia (IH) conditions. However, the specific mechanism is still unclear.
To assess the protective effect and mechanism of Tan IIA treatment on neuronal injury in HT22 cells exposed to IH.
The study established an HT22 cell model exposed to IH (0.1% O 3 min/21% O 7 min for six cycles/h). Cell viability was determined using the Cell Counting Kit-8, and cell injury was determined using the LDH release assay. Mitochondrial damage and cell apoptosis were observed using the Mitochondrial Membrane Potential and Apoptosis Detection Kit. Oxidative stress was assessed using DCFH-DA staining and flow cytometry. The level of autophagy was assessed using the Cell Autophagy Staining Test Kit and transmission electron microscopy (TEM). Western blot was used to detect the expressions of the AMPK-mTOR pathway, LC3, P62, Beclin-1, Nrf2, HO-1, SOD2, NOX2, Bcl-2/Bax, and caspase-3.
The study showed that Tan IIA significantly improved HT22 cell viability under IH conditions. Tan IIA treatment improved mitochondrial membrane potential, decreased cell apoptosis, inhibited oxidative stress, and increased autophagy levels in HT22 cells under IH conditions. Furthermore, Tan IIA increased AMPK phosphorylation and LC3II/I, Beclin-1, Nrf2, HO-1, SOD2, and Bcl-2/Bax expressions, while decreasing mTOR phosphorylation and NOX2 and cleaved caspase-3/caspase-3 expressions.
The study suggested that Tan IIA significantly ameliorated neuronal injury in HT22 cells exposed to IH. The neuroprotective mechanism of Tan IIA may mainly be related to inhibiting oxidative stress and neuronal apoptosis by activating the AMPK/mTOR autophagy pathway under IH conditions.
慢性间歇性低氧(CIH)是阻塞性睡眠呼吸暂停(OSA)的主要病理生理过程,与神经认知功能障碍密切相关。丹参酮 IIA(Tan IIA)是从丹参中提取的,用于中药(TCM)改善认知障碍。研究表明,Tan IIA 具有抗炎、抗氧化和抗凋亡特性,并在间歇性低氧(IH)条件下提供保护。然而,具体机制尚不清楚。
评估 Tan IIA 治疗对 IH 暴露 HT22 细胞神经元损伤的保护作用及机制。
本研究建立了 HT22 细胞 IH 模型(0.1% O3 min/21% O7 min,每 6 个循环/小时)。采用细胞计数试剂盒-8 测定细胞活力,采用 LDH 释放试验测定细胞损伤。采用线粒体膜电位和细胞凋亡检测试剂盒观察线粒体损伤和细胞凋亡。采用 DCFH-DA 染色和流式细胞术评估氧化应激。采用细胞自噬染色试验试剂盒和透射电镜(TEM)评估自噬水平。采用 Western blot 检测 AMPK-mTOR 通路、LC3、P62、Beclin-1、Nrf2、HO-1、SOD2、NOX2、Bcl-2/Bax 和 caspase-3 的表达。
研究表明,Tan IIA 可显著提高 IH 条件下 HT22 细胞的活力。Tan IIA 处理可改善 IH 条件下 HT22 细胞的线粒体膜电位,减少细胞凋亡,抑制氧化应激,增加自噬水平。此外,Tan IIA 增加了 AMPK 磷酸化和 LC3II/I、Beclin-1、Nrf2、HO-1、SOD2 和 Bcl-2/Bax 的表达,同时降低了 mTOR 磷酸化和 NOX2 和 cleaved caspase-3/caspase-3 的表达。
研究表明,Tan IIA 可显著改善 IH 暴露的 HT22 细胞神经元损伤。在 IH 条件下,Tan IIA 通过激活 AMPK/mTOR 自噬通路抑制氧化应激和神经元凋亡,对神经具有保护作用。